Remifentanil-propofol versus fentanyl-midazolam combinations for intracranial surgery. Influence of anaesthesia technique and intensive sedation on ventilation times and duration of stay in the ICU

被引：9

作者：

Bauer C. ^{[1
,4
]}

Kreuer S. ^{[1
]}

Ketter R. ^{[2
]}

Grundmann U. ^{[1
]}

Wilhelm W. ^{[3
]}

机构：

[1] Klinik für Anaesthesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes, Homburg/Saar

[2] Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes, Homburg/Saar

[3] Klinik für Anästhesiologie und Op. Intensivmedizin, St.-Marien-Hospital, Lünen

[4] Klinik für Anaesthesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes

来源：

Der Anaesthesist | 2007年 / 56卷 / 2期

关键词：

Anaesthesia technique; Intensive care unit stay; Neurosurgery; Sedation technique; Ventilation time;

D O I：

10.1007/s00101-006-1130-4

中图分类号：

学科分类号：

摘要：

Introduction. After neurosurgery patients often need to be sedated and ventilated in the intensive care unit (ICU). However, rapid postoperative recovery and neurological examination are particularly important for the early recognition of complications. In this retrospective study two different strategies of anaesthesia technique and ICU sedation (fentanyl-midazolam versus remifentanil-propofol) were compared. Methods. Intraoperatively, patients received continuous infusions of either fentanyl (0.2-1.0 mg/h) and midazolam (2-10 mg/h) or remifentanil (0.2-0.5 μg/kg body weight/min) and propofol (3-6 mg/kg body weight/h). After arrival in the ICU fentanyl (0.03-0.2 mg/h) and midazolam (2-12 mg/h) or remifentanil (0.1-0.2 μg/kg body weight/min) and propofol (0.5-3 mg/kg body weight/h) were infused to reach a Ramsay score of 4. The times between termination of infusion and extubation and the length of stay in the ICU were examined. Results. A total of 60 patients (n=30 each group) undergoing supratentorial brain tumour surgery were enrolled. The groups were comparable for age, weight, ASA status (American Society of Anesthesiologists) and duration of drug administration (remifentanil-propofol 528±382 min versus fentanyl-midazolam 548±360 min). Extubation times were significantly shorter after remifentanil-propofol (47 min) than after fentanyl-midazolam (481 min), and the length of stay in the ICU was also significantly reduced (1.8 days versus 3.7 days). As a result of prolonged unconsciousness and impaired neurological assessability, a brain CT scan was necessary in 3 patients after fentanyl-midazolam to exclude neurosurgical complications. Conclusion. This retrospective study demonstrates that remifentanil-propofol anaesthesia and ICU sedation are superior to the combination of fentanyl and midazolam in terms of ventilation time and length of ICU stay. Moreover, the use of fentanyl-midazolam may lead to unnecessary CT scans. © 2007 Springer Medizin Verlag.

引用

页码：128 / 132

页数：4

共 15 条

[1]

Barrientos-Vega R., Mar Sanchez-Soria M., Morales-Garcia C., Et al., Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs, Crit Care Med, 25, pp. 33-40, (1997)

[2]

Breen D., Karabinis A., Malbrain M., Et al., Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: A randomised trial, Crit Care, 9, (2005)

[3]

Casati A., Albertin A., Fanelli G., Et al., A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: Effects on postoperative recovery and respiratory function, Anesth Analg, 91, pp. 1269-1273, (2000)

[4]

Chastre J., Fagon J., Ventilator-associated pneumonia, Am J Respir Crit Care Med, 165, pp. 867-903, (2002)

[5]

Dahaba A.A., Grabner T., Rehak P.H., Et al., Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: A randomized double blind study, Anesthesiology, 101, pp. 640-646, (2004)

[6]

Egan T.D., Lemmens H.J., Fiset P., Et al., The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers, Anesthesiology, 79, pp. 881-892, (1993)

[7]

Evans T.N., Park G.R., Remifentanil in the critically ill, Anaesthesia, 52, pp. 800-801, (1997)

[8]

Glass P.S., Gan T.J., Howell S., A review of the pharmacokinetics and pharmacodynamics of remifentanil, Anesth Analg, 89, (1999)

[9]

Langer M., Mosconi P., Cigada M., Mandelli M., Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control, Am Rev Respir Dis, 140, pp. 302-305, (1989)

[10]

Martin J., Basell K., Burkle H., Et al., Analgesie und Sedierung in der Intensivmedizin. S2-Leitlinien der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin, Anaesthesiol Intensivmed, 46, pp. 1-20, (2005)

← 1 2 →